is believed to interfere with heme detoxification by binding to hematin and preventing its sequestration into inert hemozoin (Fitch, 1970 Previously, we described the selection of a HF-resisfor resistance to amantadine or halofantrine produced tant line, termed K1HF, from the CQ-resistant K1 isolate previously unknown pfcrt mutations (including S163R), We have tested the hypothesis that PfCRT might conThe importance of point mutations in pfcrt (P. falcitribute to these intriguing inverse patterns of antimalarial parum chloroquine resistance transporter) in producing susceptibility by using a combination of drug selection the chloroquine resistance (CQR) phenotype is beyond and allelic exchange approaches. These studies have dispute (Sidhu et al., 2002) . However, many questions led to the discovery of PfCRT mutations that implicate remain regarding the CQR mechanism, the role of pfcrt a defining role for this gene in antimalarial crossresismutations in crossresistance to other antimalarials, and tance. This leads us to propose a "charged drug leak" the function of PfCRT. This protein contains ten putative hypothesis to explain the CQR mechanism. transmembrane helices and is localized to the digestive vacuole (DV) membrane in the parasitized erythrocyte Results (Fidock et al., 2000) . Such a location is consistent with our understanding of the mode of action of CQ, which CQ-Resistant PfCRT Haplotypes Confer Hypersensitivity to AM 
and 7G8 and the CQ-sensitive (CQS) lines 3D7 and
for any basal effect of pfcrt allelic exchange without introducing point mutations. Each of the three CQR-GC03. Results showed much higher sensitivity to AM in Dd2 than in the CQS lines ( Figure 1A ). 7G8, which carries associated pfcrt alleles was sufficient to increase the CQ IC 50 from 29 nM for the parental GC03 line to 100-150 a mutant PfCRT haplotype that is distinct from Dd2 (Table 1) Table 2 ). These mutant CQ-resistant clones also showed increased susceptibility to MFQ and HF ( Figure  K76T polymorphism. Results were compared with J3D4, a CQ-resistant line carrying the PfCRT K76I mutation 1B; Table 2 ). The C3
Dd2
, C4
, C5
K76I
, and C6 7G8 clones displayed AM (on a Dd2-like pfcrt background) that had been selected and cloned after application of CQ pressure to 106/1 IC 50 values of 36 Ϯ 11, 26 Ϯ 14, 5 Ϯ 1, and 51 Ϯ 7 M, respectively ( Figure 1A ; Table 2 ). In comparison, both parasites (Fidock et al., 2000) . Strikingly, the acquisition of CQR in J3D4 was accompanied by a dramatic inthe initial CQS (wild-type) line GC03 and the negative control C2 GC03 were relatively insensitive to AM, with IC 50 crease in AM sensitivity, compared to the CQS (AMresistant) parents ( Figure 1A ). These data suggested values of 348 Ϯ 16 and 388 Ϯ 7 M, respectively. These assays unequivocally demonstrated a major role for that PfCRT might constitute a key determinant of this differential pattern of CQ and AM susceptibility.
pfcrt in determining parasite sensitivity to CQ and AM. We note that the subtle differences in AM susceptibility To test this hypothesis, we took advantage of recent work (Sidhu et al., 2002) in which the endogenous pfcrt between the mutant pfcrt clones mirrored differences between the nontransfected (parental) lines, providing allele of a CQS clone (GC03) was replaced by the pfcrt allele from various CQ-resistant lines (Table 1) . Clones further evidence that the degree of AM susceptibility observed in the CQ-resistant lines was largely dictated C3 Dd2 and C4 Dd2 contained the pfcrt allele from Dd2, clones C5 K76I and C6 7G8 contained the pfcrt alleles from by the mutant PfCRT haplotypes ( Figure 1A ; Tables 1  and 2 ). J3D4 and 7G8 respectively, and clone C2 GC03 controlled Table 2 . In Vitro Drug Susceptibility of the K1H6/2 Parent Line and the K1AM and K1HF Mutant Lines P. falciparum line Parasite cultures were subjected to intermittent expothis is the first validated example of a culture-adapted line that harbors these critical pfcrt mutations and that sure to increasing AM concentrations (5.5-100 M) over a 3 month period, after which time they exhibited normal is clearly and reproducibly CQS. Western blot analysis indicated equivalent PfCRT levels in the mutant and growth rates in medium containing 100 M AM. The AM IC 50 increased significantly from 27 Ϯ 7 M in the K1H6/2 control lines ( Figure 2C ). Subsequent sequencing of the full-length pfcrt cDNA revealed two novel mutations in parent line to 283 Ϯ 63 M in the AM-resistant line, denoted K1AM ( , 1996) . As discussed earlier, this occurred independently of any change in we had selected a contaminating strain that displayed this particular drug-sensitivity profile, PCR fingerprinting pfmdr1 (Ritchie et al., 1996) . Sequencing of the K1HF pfcrt cDNA revealed three polymorphisms: a codon 152 was performed with the polymorphic microsatellite marker, PfRRM, previously shown to differentiate bethreonine to alanine substitution (T152A), S163R, and a codon 275 proline to leucine substitution (P275L). Thus tween laboratory lines (Su et al., 1998). This revealed an identical banding pattern for K1H6/2 and K1AM, conthe same mutation (S163R) was selected, accompanied by the same phenotypic change, in independent experitrasting with very different patterns for all other lines used in this study (Figure 2A Figure 4A ). Similar data were obtained K1AM and K1HF resulted in a loss of a VP-sensitive mechanism that reduced the access of CQ to its hemawith K1HF (data not shown). Importantly, the binding capacity did not differ between the parental and drugtin target.
We have previously shown that while the total CQselected lines, consistent with the view that loss of VPreversible CQR restored CQ access to hematin. hematin binding capacity is similar between lines, CQresistant lines exhibit a reduced apparent affinity of satuThe dichotomous relationship between CQ and AM prompted us to look for interactions between these two rable CQ-hematin binding at equilibrium (Bray et al., also have arisen in field isolates. PCR screening for this mutation (which introduced a HinfI restriction enzyme site) in 44 geographically distinct P. falciparum field isolates identified S163R in a single isolate, Pf164, from Southeast Asia. This non-culture-adapted isolate had a CQ IC 50 value of 21 nM recorded with the WHO microtest, which classifies this as CQS. This mutation was confirmed by DNA sequence analysis of the genomic region flanking this codon. We then amplified and sequenced a 3.0 kb region of genomic DNA spanning all 13 pfcrt exons. This showed the S163R mutation to be the only codon that differed from the K1H6/2 sequence (Table  1) . We note that sequencing of this region, as well as the corresponding regions from the K1AM and K1HF mutants, showed several codon differences ( Table 1 Common to all mutant haplotypes is the pfcrt mutation K76T, previously found only in lines displaying CQR. In vivo, this mutation has proven to be a valuable molecDetection of the S163R pfcrt Mutation in a Southeast Asian Field Isolate of P. falciparum ular marker for CQR (reviewed in Waller et al., 2004) . For example, work from Mali found the presence of pfcrt Given that the pfcrt S163R mutation arose independently in resistance-selection experiments with two unalleles with the K76T mutation to be associated with a nearly 20-fold increase in CQ treatment failure (Djimde et related drugs, we hypothesized that this mutation might ., 1985) . We hypothesize that the critical diverse field isolates has identified one isolate, Pf164 from SE Asia, which harbors the pfcrt S163R mutation.
PfCRT K76T substitution in transmembrane domain I (
Figure 5B potential of the DV could therefore accelerate the efflux of charged AM and CQ from the DV, while at the same J3D4 clone (generated from the CQS 106/1 clone), which had undergone a single PfCRT K76I mutation, was retime, the inside-negative potential of the cytoplasmic compartment would trap charged drug in the cytosol. produced almost identically when this mutant allele was introduced via a CQ-independent transfection strategy Thus in parasites harboring K76T, we propose that the concentration of the charged forms of both drugs would into a CQS parasite (Table 2) . For HF, similar arguments can apply in that earlier studies have noted that CQbe greatly reduced in the DV but moderately elevated in the cytoplasm. resistant parasites can display increased susceptibility to HF (Ritchie et al., 1996) , and the introduction of mutant Accordingly, the inverse pattern of sensitivity of AM and CQ suggests that the targets of AM and CQ reside pfcrt into CQS parasites produced a consistent trend toward increased HF susceptibility ( Figure 1B) . in the cytoplasm and DV, respectively. In the case of the hematin binding drug HF, the inverse-sensitivity patPreviously, we demonstrated that CQ-resistant parasites exhibited reduced CQ access to hematin, charterns are more difficult to explain, although it is possible that HF also exerts its effects on a target outside the acterized by a reduced apparent affinity (higher K d ) of CQ binding at equilibrium, and concluded that resistant DV. Alternatively, AM and HF may both target PfCRT itself: being lipophilic weak bases, both drugs might parasites had evolved a mechanism to reduce the local CQ concentration in their DV (Bray et al., 1998). Our bind more readily to a hydrophobic region of mutant PfCRT harboring K76T. This might interfere with its func-K1H6/2 parent line harbors the CQR-associated K76T and A220S mutations and exhibits a typically low appartion, providing a potential explanation for the hypersensitivity of mutant pfcrt parasites to these drugs. One ent affinity of CQ binding (K d 150 nM; Figure 4A ). Yet the selection of these previously unidentified pfcrt mutacould then rationalize the induction of resistance to AM and HF by a compensatory mutation (S163R) that retions in the mutant lines (without loss of K76T and A220S) was associated with a significant increase in the stores a positive charge to the putative PfCRT substrate pore, making it more difficult for AM and HF to bind and apparent affinity of CQ binding. This change can be attributed to the loss of a VP-reversible mechanism that block this transport. Our model for CQR is based on the hypothesis that restricts CQ access to hematin (Table 2; Figure 4A) 
